SEC Form 4 · accession 0001209191-17-035970
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Trent G Kamke
Officer — Senior V. P., Operations
Period of report
May 24, 2017
Accepted (ET)
May 26, 2017 · 5:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 24, 2017 | M | 13,733 | $7.10 | A | 31,341 | D | |
| Common StockF2 | May 24, 2017 | S | 15,780 | $30.2802 | D | 15,561 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $7.10 | May 24, 2017 | M | 13,733 | D | Jul 26, 2011 | Jul 26, 2018 | Common Stock | 13,733 | 0 | D |
Explanation of responses
- F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- F2The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $29.70 to $30.89. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- F3This option is fully vested and exercisable.